A team of US researchers, including a scientist of Indian-origin, has shown for the first time that Covid-19 vaccines and prior Covid infections can provide broad immunity against other similar coronaviruses.

The findings build a rationale for universal coronavirus vaccines that could prove useful in the face of future epidemics.

“Until our study, what hasn’t been clear is if you get exposed to one coronavirus, could you have cross-protection across other coronaviruses? And we showed that is the case,” said lead author Pablo Penaloza-MacMaster, Assistant Professor of Microbiology-Immunology at North-western University’s Feinberg School of Medicine.

Penaloza-MacMaster collaborated with North-western Medicine physician, Igor Koralnik and Lavanya Visvabharathy, a post-doctoral research associate at Feinberg, to evaluate immune responses in humans who received Covid vaccines as well as in Covid patients.

“We found that these individuals developed antibody responses that neutralised a common cold coronavirus, HCoV-OC43,” Penaloza-MacMaster said.

“We are now measuring how long this cross-protection lasts.”

The three main families of coronaviruses that cause human disease are Sarbecovirus, which includes the SARS-CoV-1 strain that was responsible for the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS).

Other coronaviruses are SARS-CoV-2, which is responsible for Covid-19 pandemic; Embecovirus (that includes OC43) which is often responsible for the common cold; and Merbecovirus, which is the virus responsible for Middle East Respiratory Syndrome (MERS), first reported in 2012.

During the study published in the Journal of Clinical Investigation, plasma from humans who had been vaccinated against SARS-CoV-2 produced antibodies that were cross-reactive (provided protection) against SARS-CoV-1 and the common cold coronavirus (OC43).

The study found mice immunised with a SARS-CoV-1 vaccine developed in 2004 generated immune responses that protected them from intranasal exposure by SARS-CoV-2.

The team found prior coronavirus infections can protect against subsequent infections with other coronaviruses.

Mice that had been immunised with Covid-19 vaccines and later were exposed to the common cold coronavirus were partially protected against the common cold but the protection was much less robust, the study found.

The reason, the scientists explained, is because both SARS-CoV-1 and SARS-CoV-2 are genetically similar while the common cold coronavirus is more divergent from SARS-CoV-2.

“As long as the coronavirus is greater than 70 per cent related, the mice were protected,” Penaloza-MacMaster said.

“If they were exposed to a very different family of coronaviruses, the vaccines might confer less protection.”

Given how different each coronavirus family is, that answer is “likely no”, said the study authors.

However, there may be a path forward for developing a vaccine for each coronavirus family (Sarbecovirus, Embecovirus and Merbecovirus), they said.

–IANS

na/khz/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor